(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0 Ịdị ọcha ≥98.0% (HPLC) Rivaroxaban Intermediate Factory egosipụtara

(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0 Ịdị ọcha ≥98.0% (HPLC) Ụlọ ọrụ etiti Rivaroxaban

Nkọwa dị mkpirikpi:

Aha Chemical: (S)-(+)-Glycidyl Phthalimide

Ọnọdụ: 161596-47-0

Ọdịdị: White ka Gbanyụọ-Ọcha ntụ ntụ

Ịdị ọcha: ≥98.0% (HPLC)

N'etiti Rivaroxaban (CAS: 366789-02-8) na ọgwụgwọ Venous Thromboembolism (VTE)

Inquiry: alvin@ruifuchem.com

Zitere anyị email

Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Ndị nrụpụta Rivaroxaban emetụtara ndị nrụpụta:
(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0
4- (4-Aminophenyl) morpholin-3-otu CAS 438056-69-0
Rivaroxaban Intermediate CAS 446292-07-5
5-Chlorothiophene-2-Carboxylic Acid CAS 24065-33-6
5-Chlorothiophene-2-Carbonyl Chloride CAS 42518-98-9
Rivaroxaban API CAS 366789-02-8

Njirimara kemịkalụ:

Aha Chemical	(S)-(+)-Glycidyl Phthalimide
Ụdị okwu	(S) - Glycidyl Phthalimide;(S)-N-Glycidylphthalimide;Rivaroxaban Intermediate
Nọmba CAS	161596-47-0
Nọmba CAT	RF-PI128
Ọnọdụ Ahịa	N'ọkwa, Mpụta Ihe ruru Tọn
Usoro ihe omimi	C11H9NO3
Ibu molekụla	203.19
Ebe Na-agbaze	102 ℃
Ụdị	Ruifu Chemical

Nkọwapụta:

Ihe	Nkọwapụta
Ọdịdị	Ọcha ka Gbanyụọ-Ọcha ntụ ntụ
njirimara	HPLC
Ọnwụ na ihicha	≤0.50%
Sulfate ntụ ntụ	≤0.50%
Ụzọ ịdị ọcha / nyocha	≥98.0% (HPLC)
Phthalimide	≤0.10%
Single Max adịghị ọcha	≤0.50%
Mgbakọta adịghị ọcha	≤2.0%
Epichlorohydrin	≤0.10%
Glycidol	≤0.10%
Chiral ịdị ọcha	R-isomer ≤2.0% (HPLC)
Nlele ọkọlọtọ	Standardkpụrụ ụlọ ọrụ
Ojiji	Rivaroxaban (CAS: 366789-02-8) Nke etiti

(S)-(+)-Glycidyl Phthalimide CAS: 161596-47-0 Usoro njikọ

Ngwungwu & Nchekwa:

Uru:

Ajụjụ:

Ngwa:

Shanghai Ruifu Chemical Co., Ltd. bụ onye na-emepụta ihe na onye na-ebubata (S) - (+) - Glycidyl Phthalimide (CAS: 161596-47-0) nwere oke mma.Ọ bụ ihe etiti na-emekarị na njikọ nke Rivaroxaban (CAS: 366789-02-8), na ọgwụgwọ Venous Thromboembolism (VTE).

Rivaroxaban (Xarelto; CAS: 366789-02-8) bụ ọgwụ mgbochi thrombotic ma mepụta ya na mmekorita n'etiti German Bayer Pharmaceuticals na ụlọ ọrụ American Johnson.A na-egosi Rivaroxaban maka ọgwụgwọ thrombosis miri emi na pulmonary embolism, na mgbochi nke thrombosis miri emi na-emegharị ugboro ugboro na pulmonary embolism na ndị okenye.